Compare Flowserve Corporation Common Stock (FLS) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flowserve Corporation Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Flowserve Corporation Common Stock trades at $70.6 (market cap $8.96B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.8× Flowserve Corporation Common Stock's market cap, and Flowserve Corporation Common Stock pays a 1.25% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| FLS | ROIV | |
|---|---|---|
Market Cap | $8.96B | $25.09B |
Volume | 1,946,178 | 5,738,571 |
Sector | Industrials | Health |
52-Week High | $92.04 | $41.81 |
52-Week Low | $49.09 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.55B | $21.36B |
Dividend Yield | 1.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Flowserve Corporation Common Stock
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
